Host factors associated with serologic inflammatory markers assessed using multiplex assays.

[1]  J. Margolick,et al.  Data on serologic inflammatory biomarkers assessed using multiplex assays and host characteristics in the Multicenter AIDS Cohort Study (MACS) , 2016, Data in brief.

[2]  Jian Huang,et al.  Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis , 2015, PloS one.

[3]  R. Vanholder,et al.  Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study , 2015, PloS one.

[4]  R. Klein,et al.  Long‐Term Systemic Inflammation and Cognitive Impairment in a Population‐Based Cohort , 2014, Journal of the American Geriatrics Society.

[5]  U. Nöthlings,et al.  Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer , 2014, Hepatology.

[6]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[7]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[8]  L. Kingsley,et al.  Circulating Mediators of Inflammation and Immune Activation in AIDS-Related Non-Hodgkin Lymphoma , 2014, PloS one.

[9]  Deepak Saxena,et al.  Pancreatic Cancer, Inflammation, and Microbiome , 2014, Cancer journal.

[10]  B. Lau,et al.  Correlates of Elevated Interleukin-6 and C-Reactive Protein in Persons With or at High Risk for HCV and HIV Infections , 2013, Journal of acquired immune deficiency syndromes.

[11]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[12]  Joanna M. Young,et al.  Inflammatory biomarkers for predicting cardiovascular disease. , 2013, Clinical biochemistry.

[13]  M. Maes,et al.  So depression is an inflammatory disease, but where does the inflammation come from? , 2013, BMC Medicine.

[14]  I. Manabe,et al.  Macrophages and islet inflammation in type 2 diabetes , 2013, Diabetes, obesity & metabolism.

[15]  F. Lotrich,et al.  Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications , 2013, Neuroscience.

[16]  Gérard Waeber,et al.  Association between circulating cytokine levels, diabetes and insulin resistance in a population‐based sample (CoLaus study) , 2013, Clinical endocrinology.

[17]  Shenghan Lai,et al.  HIV infection and cocaine use induce endothelial damage and dysfunction in African Americans. , 2012, International journal of cardiology.

[18]  A. LaCroix,et al.  Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma. , 2012, Cancer research.

[19]  Z. Lazic,et al.  Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer , 2012 .

[20]  P. Libby.  Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[21]  F. Berrino,et al.  Factors associated with inflammation markers, a cross-sectional analysis. , 2011, Cytokine.

[22]  J. Scheller,et al.  Inhibition of Classic Signaling Is a Novel Function of Soluble Glycoprotein 130 (sgp130), Which Is Controlled by the Ratio of Interleukin 6 and Soluble Interleukin 6 Receptor* , 2011, The Journal of Biological Chemistry.

[23]  J. Goedert,et al.  Circulating cytokine levels, Epstein‐Barr viremia, and risk of acquired immunodeficiency syndrome‐related non‐Hodgkin lymphoma , 2011, American journal of hematology.

[24]  F. Konikoff,et al.  Treatment of Crohn's disease with cannabis: an observational study. , 2011, The Israel Medical Association journal : IMAJ.

[25]  Leah E. Mechanic,et al.  Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. , 2011, Journal of the National Cancer Institute.

[26]  R. Detels,et al.  B-Cell Stimulatory Cytokines and Markers of Immune Activation Are Elevated Several Years Prior to the Diagnosis of Systemic AIDS–Associated Non-Hodgkin B-Cell Lymphoma , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[27]  Vittorio Krogh,et al.  Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[28]  S. Tangye,et al.  Inflammatory Mechanisms in Obesity , 2013 .

[29]  Richard C. Shelton,et al.  Inflammation in depression: is adiposity a cause? , 2011, Dialogues in clinical neuroscience.

[30]  Antony Vinh,et al.  Inflammation, Immunity, and Hypertension , 2011, Hypertension.

[31]  W. Hörl,et al.  The versatility of HDL: a crucial anti‐inflammatory regulator , 2010, European journal of clinical investigation.

[32]  Y. Shoenfeld,et al.  Effects of tobacco smoke on immunity, inflammation and autoimmunity. , 2010, Journal of autoimmunity.

[33]  Mengling Liu,et al.  Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study , 2010, Cancer Causes & Control.

[34]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[35]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[36]  Paul M Ridker,et al.  Inflammation in atherosclerosis: from pathophysiology to practice. , 2009, Journal of the American College of Cardiology.

[37]  M. Nagarkatti,et al.  Cannabinoids as novel anti-inflammatory drugs. , 2009, Future medicinal chemistry.

[38]  H. Asaoku,et al.  Serum soluble interleukin‐2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B‐cell lymphoma , 2009, Cancer science.

[39]  J. Margolick,et al.  Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma , 2009, Cancer Causes & Control.

[40]  T. Stulnig,et al.  Obesity, Inflammation, and Insulin Resistance – A Mini-Review , 2009, Gerontology.

[41]  E. Benjamin,et al.  Relation of smoking status to a panel of inflammatory markers: the framingham offspring. , 2008, Atherosclerosis.

[42]  Ohad Parnes,et al.  Inflammation , 2008, The Lancet.

[43]  H. Dubowitz,et al.  Comparison of 3 data collection methods for gathering sensitive and less sensitive information. , 2008, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.

[44]  M. Woodward,et al.  Associations of plasma pro‐inflammatory cytokines, fibrinogen, viscosity and C‐reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study , 2008, British journal of haematology.

[45]  V. Appay,et al.  Immune activation and inflammation in HIV‐1 infection: causes and consequences , 2008, The Journal of pathology.

[46]  Haitao Chu,et al.  Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution , 2007, Statistics in medicine.

[47]  A. Talal,et al.  The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection , 2007, Journal of viral hepatitis.

[48]  Frances McCarty,et al.  Implementation of Audio Computer‐Assisted Interviewing Software in HIV/AIDS Research , 2007, The Journal of the Association of Nurses in AIDS Care : JANAC.

[49]  S. Rosenberg,et al.  Modulation by IL-2 of CD70 and CD27 Expression on CD8+ T Cells: Importance for the Therapeutic Effectiveness of Cell Transfer Immunotherapy1 , 2006, The Journal of Immunology.

[50]  E. Rimm,et al.  Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. , 2006, Atherosclerosis.

[51]  S. Kritchevsky,et al.  Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition Cohort , 2005, Cancer Epidemiology Biomarkers & Prevention.

[52]  K. Ghanem,et al.  Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients , 2005, Sexually Transmitted Infections.

[53]  A. Witkowska.  On the Role of sIL-2R Measurements in Rheumatoid Arthritis and Cancers , 2005, Mediators of inflammation.

[54]  Ildikó Kriszbacher,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, New England Journal of Medicine.

[55]  M. Pfeffer,et al.  Biomarkers of inflammation and progression of chronic kidney disease. , 2005, Kidney international.

[56]  R. Manfro,et al.  Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[57]  T. Klein.  Cannabinoid-based drugs as anti-inflammatory therapeutics , 2005, Nature Reviews Immunology.

[58]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[59]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[60]  L. Coussens,et al.  Cancer: An inflammatory link , 2004, Nature.

[61]  N. E. Buckley,et al.  Role of cannabinoid receptors in inhibiting macrophage costimulatory activity. , 2004, International immunopharmacology.

[62]  S. O’Brien,et al.  Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotype. , 2003, Clinical immunology.

[63]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[64]  J. Manson,et al.  Interrelationships Among Circulating Interleukin-6, C-Reactive Protein, and Traditional Cardiovascular Risk Factors in Women , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[65]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[66]  Hermann Brenner,et al.  Effect of alcohol consumption on systemic markers of inflammation , 2001, The Lancet.

[67]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[68]  G. Ramadori,et al.  Enhanced Expression of Interferon-Regulated Genes in the Liver of Patients with Chronic Hepatitis C Virus Infection: Detection by Suppression-Subtractive Hybridization , 2001, Journal of Virology.

[69]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[70]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[71]  J. Tschopp,et al.  BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth , 1999, The Journal of experimental medicine.

[72]  L. Pottern,et al.  Risks of Non‐Hodgkin's Lymphoma, Multiple Myeloma, and Leukemia Associated with Common Medications , 1996, Epidemiology.

[73]  J. Chmiel,et al.  The Multicenter AIDS Cohort Study: retention after 9 1/2 years. , 1995, American journal of epidemiology.

[74]  D. Taub,et al.  Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells , 1993, The Journal of experimental medicine.

[75]  T. Waldmann,et al.  The interleukin-2 receptor. , 1991, The Journal of biological chemistry.

[76]  M. Brown,et al.  Elevated concentration of soluble interleukin-2 receptors in serum of smokers and patients with lung cancer. Correlation with clinical activity. , 1990, The American review of respiratory disease.

[77]  M. Wahlqvist,et al.  Alcohol , 1984, Peptides.

[78]  L. Radloff.  The CES-D Scale , 1977 .

[79]  L. Wilkinson.  Immunity , 1891, The Lancet.

[80]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[81]  K. Jansen,et al.  Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10. , 2016, Drug and alcohol dependence.

[82]  K. Chayama,et al.  Serum interleukin‐6 associated with hepatocellular carcinoma risk: A nested case–control study , 2014, International journal of cancer.

[83]  A. Chaturvedi,et al.  Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies. , 2013, American journal of epidemiology.

[84]  Jennifer L. Gay,et al.  Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. , 2012, Cytokine.

[85]  R. Choudhury,et al.  HIV Infection , Inflammation , Immunosenescence , and Aging , 2011 .

[86]  R. Paraná,et al.  Association Between Hepatitis C and Hepatocellular Carcinoma , 2009, Journal of global infectious diseases.

[87]  G. Bray,et al.  Obesity , 2008, Annals of Internal Medicine.

[88]  M. Woodward,et al.  Associations of plasma pro-inflammatory cytokines, fibrinogen, CRP and viscosity with cardiovascular risk factors , and social deprivation: The Fourth Glasgow MONICA Study , 2008 .

[89]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[90]  G. Marks,et al.  Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma. , 1997, British Journal of Cancer.

[91]  G. Cordero.  [HIV infection]. , 1995, SIDAhora : un proyecto del Departamento de Publicaciones del PWA Coalition, NY.

[92]  L. Tartaglia,et al.  Two TNF receptors. , 1992, Immunology today.